"Incorporating Social Determinants of Health Screening into Comprehensive Medication Management", presented by Joel Farley and Swetha Pradeep

Seminar Title: "Incorporating Social Determinants of Health Screening into Comprehensive Medication Management"

Speakers: 

• Joel Farley, PhD, Professor, Associate Department Head, and Peters Endowed Chair in Pharmacy Practice Innovation, in the Department of Pharmaceutical Care & Health Systems; and Director of Graduate Studies in Social and Administrative Pharmacy (bio)
  
  
• Swetha Pradeep, PharmD, Clinical Pharmacist, Native American Community Clinic (bio)

Objectives: Following the presentation, the attendees should be able to:

1. Recognize the facilitators and barriers to implementing SDoH screening into a standardized comprehensive medication management (CMM) process in the setting of Federally Qualified Health Centers (FQHCs)
2. Understand the impact of social determinants of health (SDoH) on the ability of patients to manage medications and on clinical outcomes in chronic conditions
3. Identify opportunities for future studies and the expansion of SDoH screening in CMM practices

This seminar was recorded on October 21, 2024. Seminar Flyer 

CE for this seminar will be provided free of charge for our UMN CoP community in order to support continuing professional development. To receive CE for viewing this seminar, please complete the CE evaluation at this link: https://umn.qualtrics.com/jfe/form/SV_6G97JN1pjnDDVVI

Accreditation & Conflict of Interest Disclosure: As a Jointly Accredited Provider of Interprofessional Continuing Education Credit, the National Center for Interprofessional Practice and Education Office of Interprofessional Continuing Professional Development (OICPD) complies with the ACCME and Joint Accreditors’ Standards for Integrity and Independence in Accredited Continuing Education. The National Center has a conflict of interest policy that requires all individuals involved in the development, planning, implementation, peer review and/or evaluation of an activity to disclose any financial relationships with ineligible companies. The National Center performs a thorough review of the content of the accredited activity to ensure that any financial relationships have no influence on the content of accredited activities. All potential conflicts of interest that arise based on these financial relationships are mitigated prior to the accredited activity.

All individuals involved in the development of this learning activity were required to disclose any financial relationships with ineligible companies and any potential conflicts of interest have been mitigated.

Joel Farley - Grants/Research Support with Astra Zeneca and AstaLynx Global

Please see https://www.pharmacy.umn.edu/departments-divisions/office-professional-clinical-affairs/professional-clinical-seminar-series-archive for the links to other OPCA seminar recordings.